IBDEI11F ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16680,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,16680,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,16680,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,16681,0)
 ;;=Z80.8^^88^880^30
 ;;^UTILITY(U,$J,358.3,16681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16681,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,16681,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,16681,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,16682,0)
 ;;=Z81.8^^88^880^35
 ;;^UTILITY(U,$J,358.3,16682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16682,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,16682,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,16682,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,16683,0)
 ;;=Z82.3^^88^880^42
 ;;^UTILITY(U,$J,358.3,16683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16683,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,16683,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,16683,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,16684,0)
 ;;=Z82.49^^88^880^24
 ;;^UTILITY(U,$J,358.3,16684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16684,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,16684,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,16684,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,16685,0)
 ;;=Z82.5^^88^880^14
 ;;^UTILITY(U,$J,358.3,16685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16685,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,16685,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,16685,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,16686,0)
 ;;=Z82.61^^88^880^13
 ;;^UTILITY(U,$J,358.3,16686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16686,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,16686,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,16686,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,16687,0)
 ;;=Z82.69^^88^880^37
 ;;^UTILITY(U,$J,358.3,16687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16687,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,16687,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,16687,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,16688,0)
 ;;=Z83.3^^88^880^20
 ;;^UTILITY(U,$J,358.3,16688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16688,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,16688,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,16688,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,16689,0)
 ;;=Z83.2^^88^880^16
 ;;^UTILITY(U,$J,358.3,16689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16689,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,16689,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,16689,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,16690,0)
 ;;=Z82.71^^88^880^40
 ;;^UTILITY(U,$J,358.3,16690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16690,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,16690,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,16690,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,16691,0)
 ;;=Z82.1^^88^880^15
 ;;^UTILITY(U,$J,358.3,16691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16691,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,16691,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,16691,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,16692,0)
 ;;=Z82.2^^88^880^19
 ;;^UTILITY(U,$J,358.3,16692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16692,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
